Gene: SLC19A1
Official Full Name: solute carrier family 19 member 1provided by HGNC
Gene Summary: The membrane protein encoded by this gene is a transporter of folate and is involved in the regulation of intracellular concentrations of folate. Three transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Mar 2011]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO35365 | SLC19A1 Knockout cell line (HeLa) | Human | SLC19A1 | 1:3~1:6 | Negative | Online Inquiry |
KO35366 | SLC19A1 Knockout cell line (HCT 116) | Human | SLC19A1 | 1:2~1:4 | Negative | Online Inquiry |
KO35367 | SLC19A1 Knockout cell line (HEK293) | Human | SLC19A1 | 1:3~1:6 | Negative | Online Inquiry |
KO35368 | SLC19A1 Knockout cell line (A549) | Human | SLC19A1 | 1:3~1:4 | Negative | Online Inquiry |
SLC19A1 Gene Knockout Cell Lines are genetically engineered cell lines that have had the SLC19A1 gene disrupted or deleted, allowing researchers to study the biological implications of SLC19A1 deficiency. The SLC19A1 gene encodes a key transporter responsible for the uptake of vitamin B1 (thiamine) and other essential substrates, which are crucial for various cellular processes, including cellular metabolism and energy production. By utilizing SLC19A1 knockout cell lines, researchers can delve into the effects of thiamine deficiency on cellular function and metabolism, providing insights into disorders related to thiamine transport and its systemic impacts.
The primary mechanism of action for these knockout cell lines involves the loss of functional SLC19A1 protein, which impairs thiamine uptake. This loss prompts a cascade of physiological and biochemical changes, facilitating the investigation of metabolic pathways and the role of thiamine in both homeostasis and disease states. The insights gained from these models are invaluable in the development of novel therapeutic strategies and potential interventions for diseases linked to vitamin B1 transport deficits, such as beriberi or Wernicke-Korsakoff syndrome.
One significant advantage of using SLC19A1 Gene Knockout Cell Lines is their ability to provide a controlled environment for the systematic study of thiamine-related metabolism without the confounding factors present in whole organisms or heterogeneous tissue samples. Compared to traditional methods, these knockout cell lines allow for reproducible results and the ability to conduct high-throughput screening for potential pharmacotherapeutic agents.
For researchers and clinicians focused on metabolic disorders, nutritional deficiencies, or drug development targeting metabolic pathways, the SLC19A1 Gene Knockout Cell Lines offer an invaluable tool. The ability to pinpoint the role of thiamine in cellular outcomes facilitates a greater understanding of its therapeutic potential and relevance in human health.
At our company, we are committed to providing high-quality, innovative biological products designed to accelerate scientific discovery. Our expertise in genetic engineering and deep understanding of cellular mechanisms ensure that products like the SLC19A1 Gene Knockout Cell Lines meet the highest standards of scientific integrity and efficacy.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.